000 01616 a2200481 4500
005 20250517123732.0
264 0 _c20180326
008 201803s 0 0 eng d
022 _a1935-3456
024 7 _a10.1038/mi.2016.100
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKiniry, B E
245 0 0 _aPredominance of weakly cytotoxic, T-bet
_h[electronic resource]
260 _bMucosal immunology
_c07 2017
300 _a1008-1020 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAIDS Vaccines
_ximmunology
650 0 4 _aAnti-Retroviral Agents
_xtherapeutic use
650 0 4 _aCD8-Positive T-Lymphocytes
_ximmunology
650 0 4 _aCells, Cultured
650 0 4 _aCellular Microenvironment
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aFemale
650 0 4 _aGranzymes
_xmetabolism
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aIntestinal Mucosa
_ximmunology
650 0 4 _aMale
650 0 4 _aPerforin
_xmetabolism
650 0 4 _aRectum
_xmetabolism
650 0 4 _aT-Box Domain Proteins
_xmetabolism
650 0 4 _aTransforming Growth Factor beta
_xmetabolism
650 0 4 _aT-bet Transcription Factor
700 1 _aGanesh, A
700 1 _aCritchfield, J W
700 1 _aHunt, P W
700 1 _aHecht, F M
700 1 _aSomsouk, M
700 1 _aDeeks, S G
700 1 _aShacklett, B L
773 0 _tMucosal immunology
_gvol. 10
_gno. 4
_gp. 1008-1020
856 4 0 _uhttps://doi.org/10.1038/mi.2016.100
_zAvailable from publisher's website
999 _c26589327
_d26589327